AL-LAD Powder

AL-LAD Powder (6-allyl-6-nor-LSD) is a synthetic lysergamide and structural analogue of lysergic acid diethylamide, first characterized in the 1970s by the research team of David E. Nichols. This research chemical is distinguished by the presence of an allyl group at the N6 position of the nor-LSD backbone, a modification that alters its pharmacological profile compared to other members of the lysergamide family.

With a molecular formula of C23H27N3O and a molecular weight of 361.48 g/mol, this powder form offers high purity (>98%) and is intended exclusively for in vitro and analytical research applications. The compound exhibits preferential binding affinity for the 5-HT2A serotonin receptor subtype, with distinct receptor interaction kinetics that differentiate it from related lysergamides. Unlike some analogues, AL-LAD is not believed to function as a prodrug, acting independently as a direct agonist at serotonin receptors. Storage at -20°C in powder form ensures optimal stability and shelf life for research use.

Important Research Considerations
This substance is classified as a psychedelic and is subject to controlled substance regulations in many jurisdictions. Under the US Federal Analog Act, it is treated as an analogue of LSD, and in the UK, it is specifically named as a Class A drug. The compound is not approved for human consumption and is strictly limited to research and forensic applications.